TELA Price / Book | TELA Bio, Inc.

TELA Bio, Inc. Price/Book Ratio

The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.

TELA Bio, Inc. price/book ratio for the quarter ending 2026-06-30 was -2.12, a 125.62% decline year-over-year.
TELA Bio, Inc. price/book ratio for the quarter ending 2026-03-31 was -5.41, a 303.29% decline year-over-year.
TELA Bio, Inc. price/book ratio for the quarter ending 2025-12-31 was 8.18, a 95.75% increase year-over-year.
TELA Bio, Inc. price/book ratio for the quarter ending 2025-09-30 was 38.74, a change of 48.71 year-over-year.
TELA Bio, Inc. price/book ratio for fiscal 2026 was -2.12.
TELA Bio, Inc. price/book ratio for fiscal 2025 was 8.18, a 95.75% increase from fiscal 2024.
TELA Bio, Inc. price/book ratio for fiscal 2024 was 4.18, a 51.32% decline from fiscal 2023.
TELA Bio, Inc. price/book ratio for fiscal 2023 was 8.59, a 44.26% decline from fiscal 2022.

Available history: 2019-12-31 to 2026-06-30
Data captured: 2026-06-30

Historical Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	-2.12	$33.64M	-$15.87M
2026-03-31	-5.41	$28.15M	-$5.2M
2025-12-31	8.18	$51.66M	$6.31M
2025-09-30	38.74	$60.31M	$1.56M
2025-06-30	8.28	$76M	$9.18M
2025-03-31	2.66	$48.26M	$18.12M
2024-12-31	4.18	$118.98M	$28.46M
2024-09-30	-9.97	$62.53M	-$6.27M
2024-06-30	40.41	$115.98M	$2.87M
2024-03-31	9.72	$139.79M	$14.38M
2023-12-31	8.59	$162.15M	$18.88M
2023-09-30	6.41	$195.9M	$30.55M
2023-06-30	6.2	$247.94M	$40.01M
2023-03-31	65.13	$204.58M	$3.14M
2022-12-31	15.41	$220.4M	$14.31M
2022-09-30	7.01	$163.24M	$23.3M
2022-06-30	-66.18	$102.05M	-$1.54M
2022-03-31	16.87	$169.29M	$10.04M
2021-12-31	9.25	$185.98M	$20.1M
2021-09-30	7.14	$198.12M	$27.73M
2021-06-30	6.67	$233.14M	$34.97M
2021-03-31	5.16	$215.16M	$41.69M
2020-12-31	4.43	$217.13M	$49.03M
2020-09-30	4.24	$238.71M	$56.33M
2020-06-30	2.95	$186.79M	$63.4M
2020-03-31	3.68	$89.21M	$24.23M
2019-12-31	4.77	$147.71M	$30.96M

Annual Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	-2.12	$33.64M	-$15.87M
2025-12-31	8.18	$51.66M	$6.31M
2024-12-31	4.18	$118.98M	$28.46M
2023-12-31	8.59	$162.15M	$18.88M
2022-12-31	15.41	$220.4M	$14.31M
2021-12-31	9.25	$185.98M	$20.1M
2020-12-31	4.43	$217.13M	$49.03M
2019-12-31	4.77	$147.71M	$30.96M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Xtant Medical Holdings, Inc. (XTNT)	United States	$0.053B
Spectral AI, Inc. (MDAI)	United States	$0.052B
Sensus Healthcare, Inc. (SRTS)	United States	$0.048B	-3.24
DarioHealth Corp. (DRIO)		$0.066B	-1.39
CVRx, Inc. (CVRX)	United States	$0.067B	-2.62
NEPHROS INC (NEPH)	United States	$0.046B	23.02
SANUWAVE Health, Inc. (SNWV)	United States	$0.041B	5.47
FRACTYL HEALTH, INC. (GUTS)	United States	$0.075B	-1.18
RenovoRx, Inc. (RNXT)	United States	$0.076B	-3.62
InspireMD, Inc. (NSPR)		$0.033B